NSC |
Compound |
Enrichment |
Correlation |
NSC 667924 |
Null |
0.0252562667234373 |
0.1543887 |
NSC 684480 |
7H-Pyrido[3,2-d][1]benzazepin-6-one, 2-(3-chlorophenyl)- 5,6-dihydro-4-phenyl- |
0.0252562667234373 |
-0.060203829 |
NSC 104801 |
Cytembena |
0.0268790882218881 |
0.25128239 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0268790882218881 |
0.34994061 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.0268790882218881 |
0.20010957 |
NSC 28608 |
Null |
0.0268790882218881 |
0.19180804 |
NSC 326061 |
1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide |
0.0268790882218881 |
0.30528562 |
NSC 357777 |
Null |
0.0268790882218881 |
0.45792576 |
NSC 375162 |
Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide |
0.0268790882218881 |
0.37326286 |
NSC 608984 |
Leucinostatine D |
0.0268790882218881 |
0.51779068 |